HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SCIO-469

a small-molecule p38 mitogen-activated protein (MAP) kinase inhibitor for potential oral therapy for inflammatory disorders; in phase lib clinical trials for rheumatoid arthritis 4/2004
Networked: 12 relevant articles (3 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Medicherla, Satyanarayana: 6 articles (01/2010 - 06/2006)
2. Higgins, Linda S: 6 articles (01/2010 - 06/2006)
3. Protter, Andrew A: 5 articles (01/2010 - 05/2007)
4. Kerr, Irene: 3 articles (01/2010 - 11/2008)
5. Ma, Jing Y: 3 articles (01/2009 - 06/2006)
6. Tong, Sandra E: 2 articles (05/2012 - 05/2011)
7. Dugar, Sundeep: 2 articles (01/2009 - 10/2008)
8. Chakravarty, Sarvajit: 2 articles (01/2009 - 10/2008)
9. Navas, Tony A: 2 articles (11/2008 - 06/2006)
10. Reddy, Mamatha: 2 articles (11/2008 - 06/2006)

Related Diseases

1. Neoplasms (Cancer)
2. Rheumatoid Arthritis
3. Pain (Aches)
4. Myelodysplastic Syndromes (Myelodysplastic Syndrome)
5. Multiple Myeloma

Related Drugs and Biologics

1. Protein Kinases (Protein Kinase)
2. indole-5-carboxamide (SD 282)
3. Ibuprofen (Motrin)
4. p38 Mitogen-Activated Protein Kinases
5. Cyclooxygenase 2 (Cyclooxygenase-2)
6. Fibroblast Growth Factor 7
7. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
8. Brain Natriuretic Peptide (Natrecor)
9. Nelfinavir (Viracept)
10. Ritonavir (Norvir)

Related Therapies and Procedures

1. Stents
2. Heterologous Transplantation (Xenotransplantation)